Maxicuma® - Promotes
Joint Health and Improves
Physical Activity
Curcumin used for ages in supporting the joint health has evolved a lot in a decade. A quantum of published scientific evidence are available today, where the formulated curcumin ingredients using various technology platforms, have shown higher bioavailability of the actives. And it resulted in a clear trend of decreasing the daily dosage of curcumin in the human clinical research, thereby making the optimal use of the consumption.
In a robust RCT for joint health, with 180 participants, Maxicuma® 100 mg and 250 mg doses were studied and found to deliver statistically significant results in reducing joint pain and stiffness, and improving physical function, starting from week 4 and consistently throughout the 12-week supplementation period.
Comparing this outcome with other similar formulated curcumin ingredients in this space, which are clinically studied for mild osteoarthritic (OA) condition in healthy volunteers with validated scales like VAS and WOMAC, it is interpreted that Maxicuma ® is 4-5 folds more effective.
Read more
